Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage

Mayo Clinic Proceedings

Volumn 79, Issue 12, 2004, Pages 1495-1500

  Freeman, William D ^a   Brott, Thomas G ^a   Barrett, Kevin M ^a   Castillo, Pablo R ^a   Deen Jr , H Gordon ^a   Czervionke, Leo F ^a   Meschia, James F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

AGED; ANTICOAGULATION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DEATH; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DRAIN; DRUG DOSE REGIMEN; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEMATOMA; HOSPITAL; HOSPITALIZATION; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY; MALE; RATING SCALE; REVIEW; SURVIVAL RATE; SYMPTOM; TIME; TREATMENT OUTCOME; UNITED STATES;

EID: 9644254211     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.12.1495     Document Type: Article

References (25)

1. Hart RG. What causes intracerebral hemorrhage during warfarin therapy? Neurology. 2000;55:907-908.
2. Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001;32:2567-2574.
3. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
4. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med. 2002;137:884-888.
5. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med. 2002;28(suppl 2):S248-S255.
6. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200-215.
7. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81-84.
8. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.
9. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305.
10. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke. 1999;30:1833-1839.
11. LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR. Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery. 1992;31:678-684.
12. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke. 1998;29:1352-1357.
13. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
14. Internet Stroke Center. Stroke scales and clinical assessment tools. Available at: www.strokecenter.org/trials/scales. Accessibility verified October 22, 2004.
15. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
16. AquaMEPHYTON. Physicians' Desk Reference. 58th ed. Montvale, NJ: Thomson Medical Economics; 2004:1929-1931.
17. 1): a 5-year retrospective review. Ann Allergy Asthma Immunol. 2002;89:400-406.
18. NovoSeven [package insert]. Princeton, NJ: Novo Nordisk Pharmaceuticals, Inc; 2003.
19. Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg. 2003;98:737-740.
20. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis. 2003;14:469-477.
21. Hoffman M. Laboratory monitoring of high-dose factor VIIa therapy [letter]. Ann Intern Med. 2003;139:791.
22. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617-621.
23. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? a decision analysis. Stroke. 2003;34:1710-1716.
24. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol. 2000;57:1710-1713.
25. Yasaka M, Minematsu K, Naritomi H, Sakata T, Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost. 2003;89:278-283.